Fiona A. Simpkins

机构：University of Pennsylvania Health System, University of Pennsylvania, Philadelphia University · ORCID：0000-0002-0840-2368

发表论文 361 篇 · 总被引 4080 次 · h-index 35

代表论文

• Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR (2025 · Nature Communications · 被引 27)
• Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers (2025 · npj Precision Oncology · 被引 21)
• Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparib (2024 · Genome Medicine · 被引 16)
• Geographic Disparities in Gynecologic Oncology Clinical Trial Availability in the US (2024 · JAMA Network Open · 被引 14)
• Abstract CT262: Efficacy and safety of the combination PKMYT1-inhibitor lunresertib and ATR-inhibitor camonsertib in patients with ovarian and endometrial cancers: Phase I MYTHIC study (NCT04855656) (2025 · Cancer Research · 被引 9)
• Olaparib as treatment for platinum‐sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis (2025 · Cancer · 被引 9)